NEW YORK – Genomics plc said Monday that it has completed a $30 million funding round.
Previous investors Foresight Capital and F-Prime Capital led the unnamed round, with participation from Oxford Sciences Innovation and Lansdowne Partners.
The Oxford, UK-based genome analysis company said it would use the proceeds to "expand its work" in the area of genomic prevention.